InvestorsChronicle of the WeekWHSmith: What we knew before the sell-offThe sale of its underperforming high-street arm had left this travel retailer ready to growSave21 August 2025
InvestorsChronicle of the WeekTap into Europe’s rebound with this trustWith an excellent record of investing in quality growth companies, the fund bets big on the continent’s return to formSave14 August 2025
InvestorsChronicle of the WeekThis recovering pharma giant is a once-in-a-generation bargainOnce at the pinnacle of discovery, investors are nervous over the future. But a recovery is well under waySave14 August 2025
InvestorsChronicle of the WeekStop overlooking this FTSE 100 giant’s brilliant transformationThe events business has moved to a much better and more resilient strategy, but markets haven’t caught onSave7 August 2025
InvestorsChronicle of the WeekIt’s the right time to buy this bargain housebuilderThe industry might be in a malaise, but backing quality businesses is rarely a bad strategySave7 August 2025
InvestorsChronicle of the WeekInsure your portfolio with a fund for shaky marketsThis insurance investor offers both growth and diversificationSave31 July 2025
InvestorsChronicle of the WeekBuy into this rare UK medtech success storyThis once IPO flop is now showing great resilience and the share price is recoveringSave31 July 2025
InvestorsChronicle of the WeekPlay the social media game with this mispriced publisherThe overlooked digital brand is moving towards higher-margin sales and finding its next big market in the USSave24 July 2025
InvestorsChronicle of the WeekA microchip designer that’s ready to rival NvidiaA more liberal approach to semiconductor export rules will help boost sales at this semiconductor stockSave24 July 2025
InvestorsChronicle of the WeekA new growth era awaits this once value playThe FTSE favourite has come back from the brink, highlighting its underlying strengthsSave17 July 2025